What is JK Pharmachem Ltd (JKPHARMA) share price return in the past 10 years?

Data is not available for this company

What is the share price of JK Pharmachem Ltd (JKPHARMA)?

Company share prices are keep on changing according to the market conditions. The current trading price of JK Pharmachem Ltd (JKPHARMA) on 01-Jan-1970 05:30:00 at 05:30 is .

What is the P/E ratio of JK Pharmachem?

The latest standalone P/E ratio of JK Pharmachem as of 01-Jan-1970 is 0.00.

What is the P/B ratio of JK Pharmachem Ltd (JKPHARMA)?

The latest standalone P/B ratio of JK Pharmachem Ltd (JKPHARMA) as of 01-Jan-1970 is -0.28.

What is the 52-week high and low of JK Pharmachem Ltd (JKPHARMA)?

The 52-week high of JK Pharmachem Ltd (JKPHARMA) is Rs. 0.00 and the 52-week low is Rs. 0.00.

JK Pharmachem Ltd (JKPHARMA) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: JK Pharmachem Ltd (JKPHARMA)
Brand: JK Pharmachem

JK Pharmachem Ltd (JKPHARMA)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 500218 NSE: JKPHARMA Pharmaceuticals & Drugs | Small Cap | JK Pharmachem Share Price

JK Pharmachem Ltd (JKPHARMA)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 500218 NSE: JKPHARMA Pharmaceuticals & Drugs | Small Cap | JK Pharmachem Share Price

Key Metrics

Valuation Multiples

Market Cap

₹11 Cr.

Current Price

₹0

52-Week Low / High

₹0 / 0

TTM EPS

₹-1.3

TTM Sales

₹0.1 Cr.

Book Value per Share

₹-6.5

P/E Ratio

0.00

Industry PE

49.2

Price to Book (P/B)

-0.28

In line with its 5-year historical median

Price to Sales (P/S)

187.01

In line with its 5-year historical median

EV/EBITDA

-55.80

In line with its 5-year historical median

Dividend Yield

NAN%

Profitability Efficiency

Return on Equity (ROE)

0.00%

Return on Capital Employed (ROCE)

-3.97%

Return on Assets (ROA)

-9.21%

Operating Profit Margin

-81.6%

Net Profit Margin

-208.71%

Gross Profit Margin

-174.9%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

-86.37%

Operating Profit Growth (1 Year)

Net Profit Growth (1 Year)

Asset Quality

Promoter Holding

Pledged shares (%) of Promoter's holding (%)

Reserves

₹-103 Cr.

Equity

₹62.7 Cr.

Face Value

₹10

All Time Low / High

₹1.10 / 26.00

JK Pharmachem stock performance

Key Ratios

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Sep'96	Sep'97	Sep'98	Sep'99	Sep'00	Sep'01	Sep'02	Sep'03	Sep'04	Sep'05	TTM
ROCE % ⓘ	0%	0%	2.8%	-1.2%	-5.5%	-2.4%	10.5%	0.9%	-16.3%	-4%	-
Growth Parameters ⓘ
Sales ⓘ	0	0	71.8	68.5	72.9	70.3	95.3	78.4	38.4	5.2	0
Sales YoY Gr.	-	NA	NA	-4.5%	6.3%	-3.5%	35.5%	-17.8%	-51%	-86.4%	-
Adj EPS ⓘ	0	0	-3.6	-4.8	-3.7	-2.3	0.7	-1.1	-4.9	-1.7	-1.3
YoY Gr.	-	NA	NA	NA	NA	NA	NA	-271.2%	NA	NA	-
BVPS (₹) ⓘ	0	0	9.3	4.6	2.9	0.8	2.7	1.9	-4	-6	-6.5
Adj Net Profit ⓘ	0	0	-14.8	-19.9	-23	-14.2	4.2	-7.1	-30.5	-10.7	-8
Cash Flow from Ops. ⓘ	0	0	8.6	8	6.4	8.2	13.1	8.2	2.4	3.5	-
Debt/CF from Ops. ⓘ	0	0	16	17.4	16.3	13.1	7.9	12.3	44.1	31.4	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	-41%	-62%	-86.4%
Adj EPS ⓘ	NA	NA	-237.4%	NA
BVPSⓘ	NA	-215.8%	-230.6%	NA
Share Price	-	-	-	-

Key Financial Parameters ⓘ

	Sep'98	Sep'99	Sep'00	Sep'01	Sep'02	Sep'03	Sep'04	Sep'05	TTM
Return on Equity % ⓘ	-33.5	-50.9	-52.8	-31	9.5	-15.2	-121.5	-7629.2	21
Op. Profit Mgn % ⓘ	16.6	9.7	0.4	7.5	21.9	11.5	-37.2	-81.6	-2583.3
Net Profit Mgn % ⓘ	-20.6	-29	-31.6	-20.2	4.4	-9.1	-79.4	-204.4	-13685.1
Debt to Equity ⓘ	3.6	4.9	2.1	3	2.1	2.3	17.7	-18.2	-
Working Cap Days ⓘ	0	136	121	113	90	123	196	684	0
Cash Conv. Cycle ⓘ	0	52	45	29	29	73	123	-121	0

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Sep'98	Sep'99	Sep'00	Sep'01	Sep'02	Sep'03	Sep'04	Sep'05
Sales	71.78	68.53	72.87	70.34	95.33	78.35	38.37	5.23
Operating Expenses ⓘ +	59.92	61.90	72.62	65.17	74.47	69.37	52.72	9.81
Manufacturing Costs	20.15	21.56	30.79	26.47	28.05	31.38	23.74	1
Material Costs	29.83	30.98	33.35	30.99	35.88	30.69	20.49	5.38
Employee Cost	2.83	3.06	3.48	3.36	3.90	3.88	3.83	1.37
Other Costs ⓘ	7.10	6.30	5	4.35	6.64	3.42	4.66	2.07
Operating Profit ⓘ	11.86	6.63	0.24	5.17	20.85	8.98	-14.35	-4.59
Operating Profit Margin (%)	16.5%	9.7%	0.3%	7.3%	21.9%	11.5%	-37.4%	-87.7%
Other Income ⓘ +	2.64	1.01	0.76	0.26	0.76	0.77	0.35	0.45
Exceptional Items ⓘ	0	0	0	0	3.75	1.34	3.15	0
Interest ⓘ	19.70	17.83	14.26	10.71	10.75	7.50	7.49	6.58
Depreciation ⓘ	9.59	9.69	9.80	9.01	9.88	9.75	9.96	0.19
Profit Before Tax ⓘ	-14.79	-19.89	-23.06	-14.28	4.73	-6.17	-28.30	-10.91
Tax ⓘ	0	0	0	0	-2.05	0	0	0.01
Profit After Tax	-14.79	-19.89	-23.06	-14.28	6.78	-6.17	-28.30	-10.91
PAT Margin (%)	-20.6%	-29.0%	-31.6%	-20.3%	7.1%	-7.9%	-73.8%	-208.0%
Adjusted EPS (₹)	-3.6	-4.8	-3.7	-2.3	1.1	-1.0	-4.5	-1.7
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%

Valuation of JK Pharmachem - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Sep'98	Sep'99	Sep'00	Sep'01	Sep'02	Sep'03	Sep'04	Sep'05
Equity and Liabilities
Shareholders Fund +	44.16	33.94	53.18	38.57	49.40	43.76	6.38	-6.10
Share Capital ⓘ	41.37	51.37	94	94	94	94	94	94
Reserves ⓘ	2.79	-17.43	-40.82	-55.44	-44.60	-50.24	-87.62	-100.10
Debt +	138.16	139.82	104.33	106.83	102.84	100.08	106.73	111.08
Long Term Debt	138.16	139.82	104.33	106.83	102.84	100.08	106.73	111.08
Short Term Debt	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0
Trade Payables	11.60	11.80	13.31	12.24	7.61	7.05	6.04	3.73
Others Liabilities ⓘ	1.38	1.97	3.11	4.43	-3.01	-2.64	5.31	3.84
Total Liabilities ⓘ	195.30	187.53	173.93	162.06	156.83	148.25	124.45	112.55
Fixed Assets
Net Fixed Assets ⓘ +	157.46	150.42	141.33	133.07	124.34	115.89	106.84	106.17
Gross Block	185.71	188.29	188.87	189.51	190.51	191.66	192.49	191.80
Accumulated Depreciation	28.25	37.86	47.54	56.44	66.17	75.77	85.65	85.64
CWIP ⓘ	0.27	0.68	1.28	1.48	0.08	0.03	0	0
Investments ⓘ	0.04	0.11	0.11	0.11	0.11	0.11	0.11	0.11
Inventories	11.32	8.33	9.16	8	7.19	10.43	9.69	3.15
Trade Receivables	14.67	17.06	13.18	12.07	18.45	17	2.66	0.02
Cash Equivalents	2	1.72	0.70	0.82	1	0.22	0.39	0.09
Others Assets ⓘ	9.54	9.20	8.17	6.50	5.67	4.56	4.76	3.01
Total Assets ⓘ	195.30	187.53	173.93	162.06	156.83	148.25	124.45	112.55

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Sep'98	Sep'99	Sep'00	Sep'01	Sep'02	Sep'03	Sep'04	Sep'05
Cash Flow From Operating Activity ⓘ +	8.61	8.03	6.41	8.17	13.07	8.16	2.42	3.54
PBT ⓘ	-14.78	-19.88	-23.06	-14.28	0.98	-7.51	-31.45	-10.91
Adjustment ⓘ	29.05	28.38	25.03	20.71	21.59	17.41	17.58	7.04
Changes in Working Capital ⓘ	-4.28	0.21	4.7	1.73	-9.49	-1.75	16.29	7.4
Tax Paid ⓘ	0	0	0	0	0	0	0	0
Cash Flow From Investing Activity ⓘ +	-2.43	-3.08	-1.33	-1.04	0.24	-1.41	-0.82	0.17
Capex	-2.43	-3	-1.33	-1.04	0.24	-1.41	-0.82	0.17
Net Investments	0	-0.08	0	0	0	0	0	0
Others ⓘ	-0	0	0	0	0	0	0	0
Cash Flow From Financing Activity ⓘ +	-5.73	-5.24	-6.09	-7.01	-13.14	-7.52	-1.43	-4.01
Net Proceeds from Shares ⓘ	0	10	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	21.42	0	0	0	0	0	0
Interest Paid ⓘ	-6.48	-34.64	-4.45	-6.50	-5.80	-1.92	-1.54	0
Dividend Paid ⓘ	0	0	0	0	0	0	0	0
Others ⓘ	0.75	-2.02	-1.64	-0.50	-7.34	-5.60	0.11	-4.01
Net Cash Flow ⓘ	0.45	-0.28	-1.02	0.12	0.17	-0.77	0.17	-0.30

Financial Ratio

PARTICULARS	Sep'98	Sep'99	Sep'00	Sep'01	Sep'02	Sep'03	Sep'04	Sep'05
Ratios
ROE (%)	-38.62	-69.62	-125.23	-126.04	63.13	-43.29	0	N/A
ROCE (%)	2.78	-1.19	-5.46	-2.41	10.54	0.91	-16.27	N/A
Asset Turnover Ratio	0.43	0.42	0.47	0.49	0.69	0.59	0.33	0.05
PAT to CFO Conversion(x)	N/A	N/A	N/A	N/A	1.93	N/A	N/A	N/A
Working Capital Days
Receivable Days	63.60	72.90	65.10	56.50	50.60	71.40	80.40	79.80
Inventory Days	49	45.10	37.60	38.40	25.20	35.50	82.30	382.40
Payable Days	142	137.90	137.40	150.40	100.90	87.20	116.60	331.50

Management X-Ray

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

JK Pharmachem Ltd FAQs

The current trading price of JK Pharmachem on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of JK Pharmachem stood at ₹11.22 Cr

The latest P/E ratio of JK Pharmachem as of 31-Dec-1969 is 0.00.

The latest P/B ratio of JK Pharmachem as of 31-Dec-1969 is -0.28.

The 52-week high of JK Pharmachem is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of JK Pharmachem is ₹0.06 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that JK Pharmachem Ltd is a average quality company.

No data found

About JK Pharmachem Ltd

JK Pharmachem was incorporated on March 16, 1990. The company produces penicillin-G at its Cuddalore plant in Tamil Nadu with an installed capacity of 1,250 MMU.

The company has its own research and development facility for bio-technology research. With its net worth fully eroded, the company is under receivership now. It has been suspended from BSE on account of non compliance with listing agreement clauses.

The registered office of the company is located at A-7 SIPCOT Industrial Complex, South Arcot, Vallalar district, Cuddalore, Tamil Nadu-607005.

Business area of the company

The company is engaged in the manufacture of drugs and pharmaceuticals.

JK Pharmachem Ltd (JKPHARMA)

JK Pharmachem Ltd (JKPHARMA)

JK Pharmachem stock performance

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of JK Pharmachem - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

JK Pharmachem Ltd FAQs

About JK Pharmachem Ltd

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

JK Pharmachem Ltd (JKPHARMA)

JK Pharmachem Ltd (JKPHARMA)

JK Pharmachem stock performance

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of JK Pharmachem - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

JK Pharmachem Ltd FAQs

What is the share price of JK Pharmachem?

What is the market cap of JK Pharmachem?

What is the P/E ratio of JK Pharmachem?

What is the P/B ratio of JK Pharmachem?

What is the 52-week high and low of JK Pharmachem?

What is the TTM revenue of JK Pharmachem?

Is a good quality company?

Is undervalued or overvalued?

Is a good buy now?

About JK Pharmachem Ltd

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.